相关实验视频
Updated: Jun 18, 2026
08:28
Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
10.6K
从预制设计到实体测试:纳米粒子眼部应用的复杂要求和研究路径. 第1部分:设计,表征和初步的试验室研究
Cinzia Cimino1,2, Elide Zingale1,2, Angela Bonaccorso1,2
1Laboratory of Drug Delivery Technology, Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95124 Catania, Italy.
Molecular pharmaceutics
|October 23, 2024
概括
纳米粒子为眼部药物输送提供了一个有希望的策略,克服眼睛障碍以改善治疗. 本综述详细介绍了眼科纳米平台的初步开发和表征步骤.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术纳米技术
- 药品制造 药品制造 药品制造
背景情况:
- 眼部病理需要有效的治疗方法,但眼障碍对药物输送和患者遵守提出了挑战.
- 纳米颗粒为局部眼科药物管理提供了一个可行的策略,增强治疗结果.
- 开发纳米平台需要仔细考虑管理途径和药典标准.
研究的目的:
- 审查用于眼科应用的纳米粒子开发和表征的初步步骤.
- 引导研究人员选择适当的研究,以创建有效的纳米平台用于眼部药物输送.
- 巩固关于眼睛障碍物,施用途径和眼科治疗中纳米粒子优势的信息.
主要方法:
- 讨论眼障碍物和眼科治疗的各种施用途径.
- 分析预制步骤,包括原材料选择和定量组成.
- 详细检查纳米粒子的物理化学和技术特征测试.
- 对眼科应用中纳米粒子开发的监管要求的审查.
- 描述初步的非细胞体外评估方法.
主要成果:
- 纳米颗粒可以克服眼睛的障碍,改善药物输送和患者的遵守.
- 精心选择原材料和精确的定量成分对于纳米平台的开发至关重要.
- 物理化学和技术表征验证纳米粒子属性与监管标准相比.
- 预先的体外试验测试提供了对纳米粒子性能的初步见解.
结论:
- 本综述为研究人员开发用于眼科药物输送的纳米平台提供了全面的指南.
- 了解初步开发和表征对于成功的纳米平台至关重要.
- 需要进行进一步的体外细胞和体内生物研究,并将在随后的审查中讨论.
相关概念视频
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...